The freeze-dried formulation of the Jynneos vaccine was approved by the US Food and Drug Administration (FDA) in March. It ...

The options are for the freeze-dried version of Bavarian Nordic’s Jynneos, a formulation that allows easier stockpiling.

Bavarian Nordic is successfully navigating a sentiment-changing vaccine landscape, posting Q1 revenues significantly up from ...

Health officials are advising people at higher risk of mpox infection to consider being vaccinated with two doses of the JYNNEOS vaccine, which is available statewide. Laboratory testing of the ...

Exercised options total USD 143.6 millionSecures manufacturing and supply of freeze-dried JYNNEOS® to the U.S. in 2026 ...

According to the WHO, there are currently two vaccines available against mpox. One of them, Jynneos, produced by Danish pharmaceutical company Bavarian Nordic, is also made up of the attenuated ...

The West African Health Organisation (WAHO) has announced a major expansion of the Lassa Fever Coalition, welcoming three prominent regional health organisations.

Brazil's National Health Surveillance Agency (Anvisa) Thursday cleared the Health Ministry in separate but unanimous decisions to import and use the Jynneos / Imvanex vaccine and the drug ...

Exercised options total USD 143.6 million Secures manufacturing and supply of freeze-dried JYNNEOS® to the U.S. in 2026 The options support the manufacturing and supply of freeze-dried JYNNEOS by ...

Exercised options total USD 143.6 million Secures manufacturing and supply of freeze-dried JYNNEOS ® to the U.S. in 2026 COPENHAGEN, Denmark, May 6, 2025 – Bavarian Nordic A/S (OMX: BAVA ...